Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:18 PM
Ignite Modification Date: 2025-12-25 @ 7:51 PM
NCT ID: NCT02553135
Description: None
Frequency Threshold: 0
Time Frame: 24 months
Study: NCT02553135
Study Brief: Choroideremia Gene Therapy Clinical Trial
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Injection of AAV2-REP1 Injection of AAV-REP1, 1.00x10e11 vg, subretinal injection of total volume of 100 μL. Injection of AAV2-REP1 (10e11 vg): Single Group: single arm study 0 None 0 6 6 6 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Cataract SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.1 View
Diplopia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.1 View
Vitreous Cells SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.1 View
Anterior Chamber Cells SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.1 View
Extrafoveal macular retinal hole in area of nonfunctioning retina SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.1 View
Subretinal fluid SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.1 View
Conjunctiva hemorrhage, edema SYSTEMATIC_ASSESSMENT Eye disorders MedDRA 21.1 View